[1]
“FOLFIRI regimen as second-line treatment of metastatic gastric cancer: a retrospective analysis of efficacy, safety and prognostic factors”, Eur J Oncol, vol. 20, no. 1, pp. 32–40, Sep. 2015, Accessed: Jul. 18, 2024. [Online]. Available: https://mattioli1885journals.com/index.php/EJOEH/article/view/4168